Abstract TH873: Plasma Proteins Underlying Changes In Triglyceride Metabolism With Exercise Training

M Margaret McBride (University of South Carolina SOM, Columbia, South Carolina, United States) E Eric Leszczynski (Michigan State University, East Lansing, Michigan, United States) K Kiani Jacobs (University of South Carolina, Columbia, South Carolina, United States) J Jacob Barber (Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States) M Michael Pitre (University of South Carolina, Columbia, South Carolina, United States) P Prashant Rao (Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States) M Michael Mi (Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States) C Charles Schwartz (University of South Carolina, Columbia, South Carolina, United States) S Sujoy Ghosh C Clary Clish G Gunther Silbernagel C Claude Bouchard (PENNINGTON BIOMEDICAL RESEARCH CTR, Baton Rouge, Louisiana, United States) J Jeremy Robbins R Robert Gerszten M Mark Sarzynski (University of South Carolina, Columbia, South Carolina, United States)

Abstract

Introduction: Angiopoietin like proteins (ANGPTL) 3, 4, and 8 and their complexes (ANGPTL 3/8 and 4/8) are established inhibitors of lipoprotein lipase (LPL), all of which regulate triglyceride (TG) metabolism. Regular exercise is known to decrease plasma TG levels and increase LPL activity, and we recently showed that exercise training decreases ANGPTL3/8 levels. However, the molecular underpinnings of exercise-induced changes in regulators of TG metabolism have not been fully elucidated. The purpose of this study was to identify proteins associated with TG, LPL activity, C-terminal domain-containing (CD)-ANGPTL4, ANGPTL3/8, and ANGPTL4/8 responses to exercise training. Methods: Data on cardiometabolic phenotypes and plasma proteins (Olink 5K) measured before and after 20 weeks of endurance training were available in 617 adults (55% Female, 37% Black, 17-65 yrs) of the HERITAGE Family Study. Linear mixed models were used to test the associations of change in individual proteins with changes in TG-related traits, adjusting for age, sex, race, and baseline trait and baseline protein levels. Significant (FDR<0.05) proteins were entered in LASSO regression models with 10-fold cross-validation to identify proteomic signatures of exercise-induced changes in TG-related traits. Results: At baseline, mean age was 35 yrs, BMI 26 kg/m 2 , and lipid profile values were within the normal range. Changes in the abundance of 141 unique proteins were associated with the exercise training changes of at least one of the four traits (none associated with ΔLPL; Table 1 ), with little overlap of associated proteins across traits ( Figure 1 ). The associated proteins were overrepresented in pathways related to peptide hormone metabolism, lipoprotein assembly, remodeling and clearance, assembly of LPL and LIPC complexes, G protein-coupled receptor signaling, and clotting cascade ( Table 1 ). Proteomic signatures consisting of 24, 28, 22, and 13 proteins explained 20%, 22%, 21%, and 28% of the variance in training-induced changes in TG, ANGPTL3/8, ANGPTL4/8, and CD-ANGPTL4, respectively. Top contributing proteins for each signature are shown in Figure 2 . Conclusions: We identified several plasma proteins whose changes in response to regular exercise were associated with concomitant changes in TG and ANGPTL complex and protein traits. Our findings indicate several shared but also unique biological pathways underlying the exercise responsiveness of key regulators of TG metabolism.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (15)

M

Margaret McBride

University of South Carolina SOM, Columbia, South Carolina, United States

E

Eric Leszczynski

Michigan State University, East Lansing, Michigan, United States

K

Kiani Jacobs

University of South Carolina, Columbia, South Carolina, United States

J

Jacob Barber

Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States

M

Michael Pitre

University of South Carolina, Columbia, South Carolina, United States

P

Prashant Rao

Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States

M

Michael Mi

Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States

C

Charles Schwartz

University of South Carolina, Columbia, South Carolina, United States

S

Sujoy Ghosh

C

Clary Clish

G

Gunther Silbernagel

C

Claude Bouchard

PENNINGTON BIOMEDICAL RESEARCH CTR, Baton Rouge, Louisiana, United States

J

Jeremy Robbins

R

Robert Gerszten

M

Mark Sarzynski

University of South Carolina, Columbia, South Carolina, United States